| Document Date: 2010-06-22 02:57:33
Open Document File Size: 149,04 KBShare Result on Facebook
City Mississauga / / Company GSK / Corporate Communications GlaxoSmithKline Inc. / GlaxoSmithKline Inc. / Caring Company / / Country Canada / / Currency USD / / / Facility McMaster University / / IndustryTerm drug delivery device / chemicals / / MedicalCondition appropriate allergy / sore throat / inflammatory reaction / nasal allergies / headache / perennial allergic rhinitis / nasal congestion / About Allergic Rhinitis Allergic rhinitis / rhinitis / allergy / seasonal allergies / prevalent and chronic diseases / allergic rhinitis / seasonal allergic rhinitis / nose and runny nose / eyes and nasal congestion / Seasonal allergy / adolescent perennial allergic rhinitis / irritation / inflammation / round allergic rhinitis / back pain / / Organization Department of Medicine / McMaster University / Division of Allergy and Clinical Immunology / Stanford / / Person Paul Keith / Lauren Baswick / / / Position Associate Professor / / ProvinceOrState Ontario / / Technology drug delivery / / URL www.gsk.ca / /
SocialTag |
FOR IMMEDIATE RELEASE New treatment available in Canada for children with seasonal allergies and for adolescents and adults suffering from year round allergies AVAMYS™ is the first intra